We have previously shown that the PI3K/AKT/PTEN pathway was activated in feline mammary carcinoma and correlated with poor prognosis[22], while there are no scientific data demonstrating mTOR expression in FMC tissues and cell lines with respect to the TN phenotype and AKT activation as demonstrated in humans. This evidence concerns the gene AKT1 and breast carcinoma.